Continuous, low-dose capecitabine for patients with recurrent colorectal cancer.
Romiti A, Onesti CE, Roberto M, Barucca V, Tomao S, D'Antonio C, Durante V, Milano A, Falcone R, Di Rocco R, Righini R, Marchetti P.
Romiti A, et al. Among authors: righini r.
Med Oncol. 2015 Mar;32(3):54. doi: 10.1007/s12032-015-0496-z. Epub 2015 Feb 1.
Med Oncol. 2015.
PMID: 25638466
Free article.
Clinical Trial.